-- Jill Carroll, Director, on May 01, 2026, executed a purchase for 277,778 shares in Avalyn Pharma (AVLN) for $5,000,004. Following the Form 4 filing with the SEC, Carroll has control over a total of 2,186,562 common shares of the company, with 2,186,562 controlled indirectly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1540171/000119312526201894/xslF345X05/ownership.xml